Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Invested Capital (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Invested Capital for 2 consecutive years, with $164.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital rose 169.37% to $164.1 million in Q4 2025 year-over-year; TTM through Oct 2025 was $164.1 million, a 169.37% increase, with the full-year FY2025 number at $246.5 million, up 247.75% from a year prior.
  • Invested Capital was $164.1 million for Q4 2025 at Kestra Medical Technologies, down from $225.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $246.5 million in Q2 2025 to a low of -$236.5 million in Q4 2024.